F
Florian von Knobelsdorff-Brenkenhoff
Researcher at Ludwig Maximilian University of Munich
Publications - 62
Citations - 3674
Florian von Knobelsdorff-Brenkenhoff is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Magnetic resonance imaging & Ejection fraction. The author has an hindex of 23, co-authored 61 publications receiving 2773 citations. Previous affiliations of Florian von Knobelsdorff-Brenkenhoff include Max Delbrück Center for Molecular Medicine & Charité.
Papers
More filters
Journal ArticleDOI
Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post Processing
Jeanette Schulz-Menger,David A. Bluemke,Jens Bremerich,Scott D. Flamm,Mark A. Fogel,Matthias G. Friedrich,Raymond J. Kim,Florian von Knobelsdorff-Brenkenhoff,Christopher M. Kramer,Dudley J. Pennell,Sven Plein,Eike Nagel +11 more
TL;DR: This document addresses the need for agreement on specific standards for the interpretation and post-processing of CMR studies by providing consensus recommendations developed by the Task Force for Post Processing of the Society for Cardiovascular MR.
Journal ArticleDOI
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
Geeta Gulati,Geeta Gulati,Siri Lagethon Heck,Siri Lagethon Heck,Anne Hansen Ree,Anne Hansen Ree,Pavel Hoffmann,Jeanette Schulz-Menger,Morten W. Fagerland,Berit Gravdehaug,Florian von Knobelsdorff-Brenkenhoff,Åse Bratland,Tryggve H. Storås,Tor-Arne Hagve,Tor-Arne Hagve,Helge Røsjø,Helge Røsjø,Kjetil Steine,Kjetil Steine,Jürgen Geisler,Jürgen Geisler,Torbjørn Omland,Torbjørn Omland +22 more
TL;DR: In patients treated for early breast cancer with adjuvant anthracycline-containing regimens with or without trastuzumab and radiation, concomitant treatment with candesartan provides protection against early decline in global left ventricular function.
Journal ArticleDOI
Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update
Jeanette Schulz-Menger,David A. Bluemke,Jens Bremerich,Scott D. Flamm,Mark A. Fogel,Matthias G. Friedrich,Raymond J. Kim,Florian von Knobelsdorff-Brenkenhoff,Christopher M. Kramer,Dudley J. Pennell,Sven Plein,Eike Nagel +11 more
TL;DR: This document addresses the need for agreement on specific standards for the interpretation and post-processing of CMR studies by providing consensus recommendations developed by the Task Force for Post-Processing of the Society for Cardiovascular Magnetic Resonance.
Journal ArticleDOI
Myocardial T1 and T2 mapping at 3 T: reference values, influencing factors and implications
Florian von Knobelsdorff-Brenkenhoff,Florian von Knobelsdorff-Brenkenhoff,Marcel Prothmann,Marcel Prothmann,Matthias A Dieringer,Matthias A Dieringer,Ralf Wassmuth,Ralf Wassmuth,Andreas Greiser,Carsten Schwenke,Thoralf Niendorf,Thoralf Niendorf,Jeanette Schulz-Menger,Jeanette Schulz-Menger +13 more
TL;DR: The feasibility of T1 and T2 mapping at 3 T and reference values for the specific CMR setting are analyzed, and the diagnostic impact of the high inter-subject variability of T2 and T1 relaxation times requires further investigation.
Journal ArticleDOI
Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology
TL;DR: Issues regarding access, training and reimbursement have to be solved to offer CMR to patients in accordance with the ESC guidelines, and CMR is represented in the majority of the guidelines.